Stem cell therapy: Now the knee will be treated with stem cell therapy in the country, so much money will have to be paid for a vaccine

People suffering from knee problems in the country will now have the option of stem cell therapy along with complex treatment like knee replacement. Alkem Laboratories and Bengaluru-based biotech company Stemputix are going to commercialize StemOne, a stem cell therapy for the first time in India, to treat patients suffering from osteoarthritis, a type of arthritis. The cost of one vaccine is around Rs 1.25 lakh. In older patients of arthritis, the soft tissue that connects the bones in the knees is getting destroyed. The effect of this needle in them can last for two years or more. About 35 million people in India suffer from knee diseases. Currently, treatment options include non-steroidal anti-inflammatory drugs, hyaluronic acid vaccines, steroid vaccines, etc.

The patient himself will be the donor in the treatment Alkem and Stemputix claim this is the first 'allogeneic cell' therapy product to be approved for commercial use for the treatment of osteoarthritis using stem cells. Cell therapy is usually done through a single type of cell. Which means that in transplantation stem cells are taken from the same person who is to be transplanted i.e. the patient will be his own donor. This is a customized method of treatment, which takes time and is also very expensive. It is also used to treat cancer. The cost of stem cell cancer treatment in the US is about Rs 1 crore. But in allogeneic transplantation, stem cells are taken from someone else instead of the patient, and because of this, the product becomes commercial. Alkem has partnered with Stemputix to market its product. Product made after 12 years of research In fact, Stemputix, a company of Manipal Education and Medical Group, has developed this product after 12 years of research. The company's proprietary technology ensures that over one million doses can be produced from a single set of master cell banks. This leads to the production of large quantities of products and can be given to patients at an economical rate. According to the information, current treatment options for knees focus on temporarily relieving pain and reducing inflammation during the early stages of the disease without affecting the course of the disease. Whereas in contrast Stemone can not only relieve pain, but it also has the ability to maintain cartilage quality and prevent further disease progression in patients with second and third grades of osteoarthritis. It also reduces inflammation and irritation in the knee joint and can start the healing process.